The sample was collected by World Triathlon during an in-competition anti-doping control on 5 June 2021 in the scope of the 2021 Europe Triathlon Cup Dnipro held in Ukraine. World Triathlon was informed of the case on 24 July 2021 by the WADA-accredited laboratory of Warsaw, Poland.
The athlete, who was meant to participate in the Women’s Individual Event of the Olympic Games Tokyo 2020 on 27 July 2021, has been informed of the case and has been provisionally suspended until the resolution of the matter in line with the World Anti-Doping Code and the World Triathlon Anti-Doping Rules.
The athlete has the right to request the analysis of the B-sample and to challenge the imposition of the provisional suspension before the Court of Arbitration for Sport – Anti-Doping Division (CAS ADD).
Considering that the ITA is leading the anti-doping program on-site for the Olympic Games Tokyo 2020, World Triathlon entrusted the ITA to handle the results management of this case.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
Update – 26 July 2021:
The athlete requested CAS ADD to lift the provisional suspension. Following an ad hoc hearing handled by the ITA on behalf of World Triathlon, CAS ADD confirmed the provisional suspension imposed on 25 July 2021.
Update – 8 August 2021:
Another sample collected from the athlete has returned an AAF for recombinant erythropoietin (EPO) (S2. Peptide, Hormones, Growth Factors, related substances, and mimetics). The additional sample was collected by the ITA under the Testing Authority of the International Olympic Committee during an out-of-competition anti-doping control on 23 July 2021 in Tokyo, Japan. The result was reported by the WADA-accredited laboratory of Tokyo on 28 July 2021. Since the athlete was already provisionally suspended when the second AAF was reported and that she was no longer at the Olympic Games Tokyo 2020, the case was referred to World Triathlon for follow-up results management.